Jokilammi A - Search Results

1

Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling.

Paatero I, Jokilammi A, Heikkinen PT, Iljin K, Kallioniemi OP, Jones FE, Jaakkola PM, Elenius K. Paatero I, et al. Among authors: jokilammi a. J Biol Chem. 2012 Mar 23;287(13):9659-9671. doi: 10.1074/jbc.M111.299537. Epub 2012 Feb 3. J Biol Chem. 2012. PMID: 22308027 Free PMC article.

2

Human Metaplastic Breast Carcinoma and Decorin.

Boström P, Sainio A, Eigėlienė N, Jokilammi A, Elenius K, Koskivuo I, Järveläinen H. Boström P, et al. Among authors: jokilammi a. Cancer Microenviron. 2017 Dec;10(1-3):39-48. doi: 10.1007/s12307-017-0195-8. Epub 2017 Jun 26. Cancer Microenviron. 2017. PMID: 28653173 Free PMC article.

3

Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target.

Heliste J, Jokilammi A, Paatero I, Chakroborty D, Stark C, Savunen T, Laaksonen M, Elenius K. Heliste J, et al. Among authors: jokilammi a. BMC Cardiovasc Disord. 2018 Oct 20;18(1):196. doi: 10.1186/s12872-018-0933-y. BMC Cardiovasc Disord. 2018. PMID: 30342492 Free PMC article.

4

Decorin Expression in Human Vulva Carcinoma: Oncosuppressive Effect of Decorin cDNA Transduction on Carcinoma Cells.

Nyman MC, Jokilammi AB, Boström PC, Kurki SH, Sainio AO, Grenman SE, Orte KJ, Hietanen SH, Elenius K, Järveläinen HT. Nyman MC, et al. Among authors: jokilammi ab. J Histochem Cytochem. 2019 Jul;67(7):511-522. doi: 10.1369/0022155419845373. Epub 2019 Apr 22. J Histochem Cytochem. 2019. PMID: 31009269 Free PMC article.

5

Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia.

Heliste J, Jokilammi A, Vaparanta K, Paatero I, Elenius K. Heliste J, et al. Among authors: jokilammi a. Sci Rep. 2021 Aug 17;11(1):16661. doi: 10.1038/s41598-021-96033-z. Sci Rep. 2021. PMID: 34404849 Free PMC article.

6

An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation.

Vaparanta K, Jokilammi A, Tamirat M, Merilahti JAM, Salokas K, Varjosalo M, Ivaska J, Johnson MS, Elenius K. Vaparanta K, et al. Among authors: jokilammi a. Nat Commun. 2022 Nov 14;13(1):6953. doi: 10.1038/s41467-022-34539-4. Nat Commun. 2022. PMID: 36376313 Free PMC article.

7

STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth.

Vaparanta K, Jokilammi A, Paatero I, Merilahti JA, Heliste J, Hemanthakumar KA, Kivelä R, Alitalo K, Taimen P, Elenius K. Vaparanta K, et al. Among authors: jokilammi a. EMBO Rep. 2023 May 4;24(5):e56689. doi: 10.15252/embr.202256689. Epub 2023 Apr 3. EMBO Rep. 2023. PMID: 37009825 Free PMC article.

8

Endosialidases: Versatile Tools for the Study of Polysialic Acid.

Jakobsson E, Schwarzer D, Jokilammi A, Finne J. Jakobsson E, et al. Among authors: jokilammi a. Top Curr Chem. 2015;367:29-73. doi: 10.1007/128_2012_349. Top Curr Chem. 2015. PMID: 22851159 Review.

9

Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma.

Korja M, Jokilammi A, Salmi TT, Kalimo H, Pelliniemi TT, Isola J, Rantala I, Haapasalo H, Finne J. Korja M, et al. Among authors: jokilammi a. BMC Cancer. 2009 Feb 17;9:57. doi: 10.1186/1471-2407-9-57. BMC Cancer. 2009. PMID: 19222860 Free PMC article.

10

Identification of amino acid residues at the active site of endosialidase that dissociate the polysialic acid binding and cleaving activities in Escherichia coli K1 bacteriophages.

Jakobsson E, Jokilammi A, Aalto J, Ollikka P, Lehtonen JV, Hirvonen H, Finne J. Jakobsson E, et al. Among authors: jokilammi a. Biochem J. 2007 Aug 1;405(3):465-72. doi: 10.1042/BJ20070177. Biochem J. 2007. PMID: 17394421 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page